Log In
BCIQ
Print this Print this
 

Osphena, ospemifene (Ophena)

  Manage Alerts
Collapse Summary General Information
Company QuatRx Pharmaceuticals Co.
DescriptionSelective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor (ESR1)
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat moderate to severe dyspareunia due to postmenopausal vulvovaginal atrophy; Treat moderate to severe vaginal dryness due to menopause; Treat postmenopausal vulvovaginal atrophy
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2010

Undisclosed

$25.0M

Undisclosed

Get a free BioCentury trial today